2022年9月的雷暴喘疫情在中国西北的林:一个7年的回顾性分析 (2018-2024)
Meimei Liu1,2, Wenjing Ye3, Xin Liu1,2
1Department of Allergy, Yulin Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, P.R. China.
The Journal of international medical research
|February 23, 2026
概括
雷暴喘在中国西北地区构成重大威胁,与花粉和风暴有关的病例激增. 早期预警系统对于受影响地区的公共卫生至关重要.
科学领域:
- 环境健康 环境健康
- 流行病学 流行病学
- 过敏学 过敏学
背景情况:
- 雷暴喘爆发是一个日益严重的公共卫生问题.
- 了解流行病学模式对于有效管理至关重要.
研究的目的:
- 为了记录一个特定的雷暴喘疫情在乌林,中国西北 (2022年9月).
- 分析2018年至2024年过敏性呼吸道疾病的流行病学趋势.
- 为了确定与疫情相关的风险因素.
主要方法:
- 追溯观察性研究设计.
- 利用了来自林医院和西安嘉通大学第一附属医院的患者数据.
- 包括对医院信息系统,病历和花粉监测数据的分析.
主要成果:
- 过敏性呼吸道疾病的年均发病率从4778例增加到26459例 (2018-2024年).
- 紧急访问在2022年9月雷暴期间达到2185个峰值.
- 在住院患者中,58%没有先前的喘诊断,70.9%患有过敏性鼻炎,59.1%对花粉敏感.
结论:
- 雷暴喘是中国西北地区的一个重大公共卫生问题.
- 花粉和雷暴条件的融合引发了疫情爆发.
- 对于易受感染的地区,迫切需要集成的预警系统.
更多相关视频
05:56A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
5.5K
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
2.2K
相关概念视频
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-II: Pathophysiology and Classification
4.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
Antiasthma Drugs: Methylxanthines
1.8K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.8K
